Its about changes on the cellular level that affect your physical healthy and mental clarity
Apostolopoulos, V., Bojarska, J., Chai, T
In 2023, the FDA finalized its reclassification of several peptide compounds including BPC-157, TB-500 (thymosin beta-4), CJC-1295, ipamorelin, and others removing them from the list of bulk drug substances permitted for compounding under Section 503A and 503B of the Food Drug and Cosmetic Act
The bodys response depends on factors like overall health, the condition being treated, and the substances infused
In addition, the growth hormone levels were reportedly increased in these subjects, suggesting the action the peptides had on both food intake and growth hormone levels